via NDTV Food
Doctors may soon be able to detect and monitor a patient’s cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
W. Andy Tao, a professor of biochemistry and member of the Purdue University Center for Cancer Research and colleagues identified a series of proteins in blood plasma that, when elevated, signify that the patient has cancer. Their findings were published in the early edition of the Proceedings of the National Academy of Sciences.
Tao’s work was done with samples from breast cancer patients, but it is possible the method could work for any type of cancer and other types of diseases. The work relies on analysis of microvesicles and exosomes in blood plasma.
Protein phosphorylation, the addition of a phosphate group to a protein can lead to cancer cell formation. So phosphorylated proteins, known as phosphoproteins, have been seen as prime candidates for cancer biomarkers. Until now, however, scientists weren’t sure identification of phosphoproteins in blood was possible because the liver releases phosphatase into the bloodstream, which dephosphorylates proteins.
“There are so many types of cancer, even multiple forms for different types of cancer, that finding biomarkers has been discouraging,” Tao said. “This is definitely a breakthrough, showing the feasibility of using phosphoproteins in blood for detecting and monitoring diseases.”
Tao and his colleagues found nearly 2,400 phosphoproteins in a blood sample and identified 144 that were significantly elevated in cancer patients. The study compared 1-milliliter blood samples from 30 breast cancer patients with six healthy controls.
The researchers used centrifuges to separate plasma from red blood cells, and high-speed and ultra-high-speed centrifuges to further separate microvesicles and exosomes. Those particles, which are released from cells and enter the bloodstream, may play a role in intercellular communication and are thought to be involved in metastasis, spreading cancer from one place to another in the body. They also encapsulate phosphoproteins, which Tao’s team identified using mass spectrometry.
“Extracellular vesicles, which include exosomes and microvesicles, are membrane-encapsulated. They are stable, which is important,” Tao said. “The samples we used were 5 years old, and we were still able to identify phosphoproteins, suggesting this is a viable method for identifying disease biomarkers.”
A simple blood test for cancer would be far less invasive than scopes or biopsies that remove tissue. A doctor could also regularly test a cancer patient’s blood to understand the effectiveness of treatment and monitor patients after treatment to see if the cancer is returning.
“There is currently almost no way to monitor patients after treatment,” Tao said. “Doctors have to wait until cancer comes back.”
Timothy Ratliff, director of the Purdue University Center for Cancer Research, said the findings are promising for early detection of cancer.
“The vesicles and exosomes are present and released by all cancers, so it could be that there are general patterns for cancer tissues, but it’s more likely that Andy will develop patterns associated with different cancers. It’s really exciting,” Ratliff said. “Early detection in cancer is key and has been shown to clearly reduce the death rate associated with the disease.”
Tao plans to analyze increased levels of phosphoproteins in various types of cancer to determine whether there are patterns that would signify the type of cancer a patient has. His company, Tymora Analytical, is also developing technology that would allow doctors to insert blood samples onto a cartridge and analyze phosphoproteins present, eliminating the need for ultra-high-speed centrifuges that aren’t practical in clinical settings.
Learn more: Breakthrough discovery may make blood test feasible for detecting cancer
[osd_subscribe categories=’cancer-blood-test’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “CANCER BLOOD TEST”‘]
Receive an email update when we add a new CANCER BLOOD TEST article.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- KDx Diagnostics Inc. and UroGPO Announce a Partnership to Offer the URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United Stateson May 27, 2022 at 3:38 pm
KDx Diagnostics and UroGPO announced today the partnership to provide the URO17® test (Research Use Only in the US) for the detection of bladder cancer. URO17® is a non-invasive urine test with high ...
- Could a Novel Blood Test Speed Up the Diagnosis of Ovarian Cancer?on May 27, 2022 at 7:58 am
A NEW blood test could be used to diagnose ovarian cancer more efficiently, and may lead to reduced biopsies according to a new study carried out by researchers from the University of Manchester, UK.
- Companies partner on early lung cancer detection blood teston May 27, 2022 at 6:42 am
Currently, there are no simple, specific blood tests for the early detection of lung cancer, which is especially important as targeted interventions can improve access to cancer care and save lives.
- CorePath Laboratories Announces Partnership with Cizzle Biotechnology to Develop Simple Blood Test for Early Lung Cancer Detectionon May 26, 2022 at 6:17 am
CorePath is excited to announce a partnership with Cizzle Biotechnology, a UK based diagnostics developer, to develop and offer a proprietary early-stage lung ...
- StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USAon May 25, 2022 at 10:04 am
First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND, VA ...
- Are you at risk for bladder cancer? One lifestyle change you should make immediatelyon May 20, 2022 at 1:00 pm
What are the signs and symptoms of bladder cancer, and what are its risk factors? Here's what you need to know, according to an expert.
- Standard blood cancer test holds clear clues of rare IgD multiple myelomaon May 18, 2022 at 10:03 pm
A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.
- Standard test for multiple myeloma provides clues of a rare, more deadly typeon May 18, 2022 at 9:03 pm
A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.
- Prostate cancer screening is better than originally thought, especially for Black men, study sayson May 18, 2022 at 5:54 pm
A blood test to screen for prostate cancer may be better at doing so than experts originally thought, particularly among Black men, according to a new study. There’s no standard test for prostate ...
via Bing News